Scope: March 11, 2013
In case you missed it yesterday, NPR had a segment discussing the importance of having more diversity among participants of clinical trials:
…[A]ccording to the National Cancer Institute, African-Americans only accounted for 9.2 percent of the patients involved in its clinical trials, even though African-Americans are more likely than any other racial group to die of the disease.
But bringing more African-Americans into clinical trials means overcoming decades of suspicion and distrust. Read more